| P50 | author | Jacqueline Bresnahan | Q67524117 |
| P2093 | author name string | Marco D Sorani | |
| | Michael S Beattie | |
| P2860 | cites work | Gangliosides for acute spinal cord injury | Q24244162 |
| | Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov | Q24289273 |
| | Classification of traumatic brain injury for targeted therapies | Q24656273 |
| | Trial registration: a great idea switches from ignored to irresistible | Q31110462 |
| | Common data elements for research on traumatic brain injury and psychological health: current status and future development | Q33736423 |
| | Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design | Q33932859 |
| | Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov | Q34029690 |
| | Bridging the gap: from discovery to clinical trials in spinal cord injury | Q34143882 |
| | Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I | Q34740531 |
| | Overview of the national spinal cord injury statistical center database. | Q35025880 |
| | Spinal cord injury: promising interventions and realistic goals | Q35539829 |
| | Update on pharmaceutical trials in acute spinal cord injury. | Q35918240 |
| | Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study | Q35956121 |
| | Influence of age and gender on rehabilitation outcomes in nontraumatic spinal cord injury. | Q36076637 |
| | Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). | Q36104338 |
| | Myelin pathogenesis and functional deficits following SCI are age-associated | Q36243141 |
| | Clinical trials in spinal cord injury | Q36455837 |
| | Changing face of spine trauma care in North America | Q36473719 |
| | Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations | Q36672603 |
| | Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics | Q36688373 |
| | Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures | Q36688379 |
| | Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials | Q36688383 |
| | Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website | Q37769091 |
| | Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials | Q38548253 |
| | Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group | Q39219227 |
| | Future directions for spinal cord injury research: recent developments and model systems contributions. | Q39778384 |
| | The impact of co-morbidities on age-related differences in mortality after acute traumatic spinal cord injury | Q39996233 |
| | Rehabilitation following injury to the spinal cord | Q40882102 |
| | Methods of a multisite randomized clinical trial of supported employment among veterans with spinal cord injury. | Q44336839 |
| | GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trials. | Q45983478 |
| | Outcome measures: evolution in clinical trials of neurological/functional recovery in spinal cord injury | Q48594645 |
| | Clinical trial registration: a statement from the International Committee of Medical Journal Editors. | Q55038991 |
| | A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury | Q56775114 |
| | Registries and Registration of Clinical Trials | Q57419704 |
| | Upper- and Lower-Extremity Motor Recovery After Traumatic Cervical Spinal Cord Injury: An Update From the National Spinal Cord Injury Database | Q57671785 |
| | Emerging drugs for spinal cord injury | Q57839539 |
| | ALS clinical trials: Do enrolled patients accurately represent the ALS population? | Q60469036 |
| | Efficacy of Methylprednisolone in Acute Spinal Cord Injury | Q70309275 |
| | Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial | Q85056956 |
| P433 | issue | 9 | |
| P304 | page(s) | 1736-1746 | |
| P577 | publication date | 2012-04-02 | |
| P1433 | published in | Journal of Neurotrauma | Q15716774 |
| P1476 | title | A quantitative analysis of clinical trial designs in spinal cord injury based on ICCP guidelines | |
| P478 | volume | 29 | |